# Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

> **NCT00054327** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 34 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases

## Interventions

- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **RADIATION:** radiation therapy
- **DRUG:** Etoposide
- **PROCEDURE:** Stem Cell Transfusion

## Key facts

- **NCT ID:** NCT00054327
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00054327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00054327, "Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00054327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*